Emely L. Verweyen on Muck Rack

Emely L. Verweyen

As seen in: The Lancet, The Journal of Clinical Investigation
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Emely L.

Contact Emely L., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Population-level single-cell genomics reveals conserved gene programs in systemic juvenile idiopathic arthritis

|
By Emely L. Verweyen, Kairavee Thakkar, Sanjeev Dhakal, Elizabeth Baker
| The Journal of Clinical Investigation
ResearchInflammation Open Access | 10.1172/JCI166741 J Clin Invest. https://doi.org/10.1172/JCI166741. Copyright © 2023, Verweyen et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. View PDF Abstract Systemic autoimmune and autoinflammatory diseases are characterized by genetic and cellular heterogeneity.
Open in Who Shared Issue with article?

Distinct Gene Expression Signatures Characterize Strong Clinical Responders Versus Nonresponders to Canakinumab in Children With Systemic Juvenile Idiopathic Arthritis

|
By Emely L. Verweyen, Alex Pickering, Alexei A. Grom, Grant Schulert
| Wiley Online Library Verified
Brief Report Emely L. Verweyen, Corresponding Author emely.verweyen@cchmc.org orcid.org/0000-0001-5943-2148 Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio Address correspondence to Grant Schulert, MD, PhD, or Emely Verweyen, PhD, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229. Email: grant.schulert@cchmc.org or emely.verweyen@cchmc.org.
Open in Who Shared Issue with article?

Inflammatory biomarkers in COVID-19-associated multisystem inflammatory syndrome in children, Kawasaki disease, and macrophage activation syndrome: a cohort study

|
By Emely L. Verweyen, Gwendolyn M. Clay, Ysabella M. Esteban, Jackeline J Rodriguez-Smith
| The Lancet Verified
Summary Background Multisystem inflammatory syndrome in children (MIS-C) is a potentially life-threatening hyperinflammatory syndrome that occurs after primary SARS-CoV-2 infection. The pathogenesis of MIS-C remains undefined, and whether specific inflammatory biomarker patterns can distinguish MIS-C from other hyperinflammatory syndromes, including Kawasaki disease and macrophage activation syndrome (MAS), is unknown.
Open in Who Shared Issue with article?
See all 3 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified